Proteomics Market Outlook 2029: Presents Market Insights & Depth Analysis

Proteomics market is anticipated to grow at a significant CAGR of 9.7% during the forecast period.  Personalized medicine has entered mainstream clinical practice and is transforming the way many diseases are detected, classified, and treated. It has become a fundamental topic of research in the healthcare business. Oncology is one area where these gains are particularly noticeable. The number of tailored medications, therapies, and diagnostic devices has expanded dramatically from 21% in 2014 to 42% in 2018, according to the Personalized Medicine Coalition report (2018), and this trend is projected to continue in the coming years. Furthermore, during the previous five years, biopharmaceutical companies have nearly doubled their R&D investments in customized medicine, and this trend is projected to continue in the next five years.

Proteomic analysis is a strong and appealing method for determining the molecular profiles of various tissues, whether healthy or sick. Personalized proteomics, also known as proteome profiling, is the next great step in personalized medicine; it clarifies illness pathomechanisms. This research identifies several indicators for a given condition and aids in the identification of protein targets for licensed medications, enabling therapeutic repositioning. This will have a direct impact on clinical practices by impacting key management and care features. These biomarkers can also be investigated for their therapeutic potential and future validation, as well as their utility as repeatable, sensitive, and specific diagnostic indicators.

The key companies operating in the industry are highly inclined towards the adoption of different growth strategies including capacity expansion, partnerships, mergers and acquisitions, geographical expansion, new product launches, and product innovation to remain competitive in the marketplace. For instance, Perkin Elmer introduced the SARS-COV-2 Antigen Elisa Test in 2020. The IP2 software from Integrated Proteomics Applications was purchased by Bruker Corp. in 2020.

To Request a Sample of our Report on Proteomics market :  https://www.omrglobal.com/request-sample/proteomics-market

Market Coverage

The market number available for - 2022-2030
Base year- 2022
Forecast period- 2023-2030

Segment Covered- 

By Product and Services
By Application

Regions Covered-

North America
Europe
Asia-Pacific
Rest of the World

Competitive Landscape- Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Bruker Corp., Danaher Corp., GE Healthcare, Merck KGaA, Promega Corporation, Thermo Fisher Scientific, Inc., and Waters Corp, among others.

Proteomics Market Report Segment

By Product

Instrumentation Technology
Spectroscopy
Chromatography
Electrophoresis
Protein Microarrays
X-Ray Crystallography
Other Instrumentation Technologies
Reagents
Software and Services

By Application

Clinical Diagnostics
Drug Discovery
Other Applications

A full report of Proteomics Market is available at: https://www.omrglobal.com/industry-reports/proteomics-market

Proteomics Market- Segment by Region

North America          

United States
Canada

Europe

Germany
United Kingdom
France
Spain
Italy
Rest of Europe

Asia-Pacific   

China
Japan
India
Rest of Asia-Pacific

Rest of the World

Middle East & Africa
Latin America

Company Profiles

Activx Biosciences, Inc.
Affymetrix, Inc.
Agilent Technologies
Amgen Inc
Applied Biosystems, Inc.
ASTERAND PLC
BAYER AG
Beckman Coulter, Inc.
Becton, Dickinson, And Co.
Biacore International Ab

Reasons to Buy From us -

We cover more than 15 major industries, further segmented into more than 90 sectors.
More than 120 countries are for analysis.
Over 100+ paid data sources mined for investigation.
Our expert research analysts answer all your questions before and after purchasing your report.

 

Media Contact:

Contact Person: Mr. Anurag Tiwari

Email: anurag@omrglobal.com

Contact no: +91 780-304-0404

Company Name: Orion Market Research

 About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.

This release was published on openPR.